ALASCCA: an aspirin a day keeps colorectal cancer away
- Study type
- Other
- Study name
- ALASCCA
- Source
- Nat Rev Clin Oncol · 2025
In plain words
This is a short commentary in a specialist cancer journal, and its title refers to the role of aspirin in relation to bowel cancer. The available record gives no details about results, dose or patient groups. Taking aspirin without talking to a doctor is not recommended, as it can cause side effects such as bleeding.
Clinical significance and place in guidelines
From this record, which has no abstract, the clinical impact or any change in practice cannot be assessed. To learn about the findings and the place of aspirin in treatment or prevention, the full text of the paper and the original trial should be reviewed, and its status checked in authoritative clinical guidelines.
Limitations
The PubMed record contains only the title and bibliographic information and has no abstract or data on study design, population, results or adverse events. This paper is not the primary report of the trial, and the original paper should be consulted for details.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.